End-of-study safety, immunogenicity and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24–45 years of age

Authors

Keywords

Journal

Volume 105, Issue 1, Pages 28-37

Publisher

Springer Nature

Online

2011-06-01

DOI

10.1038/bjc.2011.185

References

View 4 related references

Explore over 38,000 international journals covering a vast array of academic fields.

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now